Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β₂-agonist via dry-powder inhalers and pressurized metered-dose inhalers

References

• ManninoDMBuistASGlobal burden of COPD: risk factors, prevalence, and future trendsLancet2007370958976577317765526
   PubMed Web of Science ®Google Scholar
• SorianoJBRodríguez-RoisinRChronic obstructive pulmonary disease overviewProc Am Thorac Soc2011836336721816993
   PubMedGoogle Scholar
• MurphySLKochanekKDXuJQAriasEMortality in the United States, 2014NCHS data brief, no 229Hyattsville, MDNational Center for Health Statistics2015
   Google Scholar
• Dwyer-LindgrenLBertozzi-VillaAStubbsRWTrends and patterns of differences in chronic respiratory disease mortality among us counties, 1980–2014JAMA2017318121136114928973621
   PubMed Web of Science ®Google Scholar
• VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
   PubMed Web of Science ®Google Scholar
• FosterTSMillerJDMartonJPCaloyerasJPRussellMWMenzinJAssessment of the economic burden of COPD in the US: A review and synthesis of the literatureCOPD2006321121817361502
   PubMedGoogle Scholar
• SchwabPDhamaneADHopsonSDImpact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare populationInt J Chron Obstruct Pulmon Dis20171273574428260880
   PubMed Web of Science ®Google Scholar
• DalalAAChristensenLLiuFRiedelAADirect costs of chronic obstructive pulmonary disease among managed care patientsInt J Chron Obstruct Pulmon Dis2010534134921037958
   PubMedGoogle Scholar
• FordESMurphyLBKhavjouOGilesWHHoltJBCroftJBTotal and state-specific medical and absenteeism costs of COPD among adults aged $18 years in the United States for 2010 and projections through 2020Chest20151471314525058738
   PubMed Web of Science ®Google Scholar
• QaseemAWiltTJWeinbergerSEDiagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory SocietyAnn Intern Med2011155317919121810710
   PubMed Web of Science ®Google Scholar
• CrinerGJBourbeauJDiekemperRLExecutive summary: prevention of acute exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society GuidelineChest2015147488389325320966
   PubMed Web of Science ®Google Scholar
• MahonJFitzgeraldAGlanvilleJMisuse and/or treatment delivery failure of inhalers among patients with asthma or COPD: A review and recommendations for the conduct of future researchRespir Med20171299811628732842
   PubMed Web of Science ®Google Scholar
• AroraPKumarLVohraVEvaluating the technique of using inhalation device in COPD and bronchial asthma patientsRespir Med2014108799299824873874
   PubMed Web of Science ®Google Scholar
• VogelmeierCFCrinerGJMartinezFJGlobal strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. Gold executive summaryAm J Respir Crit Care Med2017195555758228128970
   PubMed Web of Science ®Google Scholar
• KlijnSLHiligsmannMEversSRomán-RodríguezMvan der MolenTvan BovenJFMEffectiveness and success factors of educational inhaler technique interventions in asthma & COPD patients: a systematic reviewNPJ Prim Care Respir Med20172712428408742
   PubMed Web of Science ®Google Scholar
• SanchisJGichIPedersenSAerosol Drug Management Improvement Team (ADMIT). Systematic review of errors in inhaler use: Has patient technique improved over time?Chest2016150239440627060726
   PubMed Web of Science ®Google Scholar
• KaplanAPriceDMatching inhaler devices with patients: The role of the primary care physicianCan Respir J20182018947305129951160
   PubMed Web of Science ®Google Scholar
• JarvisSIndPWShinerRJInhaled therapy in elderly COPD patients; time for re-evaluation?Age Ageing200736221321817267450
   PubMed Web of Science ®Google Scholar
• LohCHPetersSPLovingsTMOharJASuboptimal inspiratory flow rates are associated with chronic obstructive pulmonary disease and all-cause readmissionsAnn Am Thorac Soc20171481305131128406710
   PubMed Web of Science ®Google Scholar
• MahlerDAWatermanLAGiffordAHPrevalence and COPD phenotype for a suboptimal peak inspiratory flow rate against the simulated resistance of the Diskus® dry powder inhalerJ Aerosol Med Pulm Drug Deliv201326317417923025451
   PubMed Web of Science ®Google Scholar
• SharmaGMahlerDAMayorgaVMDeeringKLHarshawOGanapathyVPrevalence of low peak inspiratory flow rate at discharge in patients hospitalized for copd exacerbationChronic Obstr Pulm Dis20174321722428848933
   PubMed Web of Science ®Google Scholar
• MelaniASBonaviaMCilentiVInhaler mishandling remains common in real life and is associated with reduced disease controlRespir Med2011105693093821367593
   PubMed Web of Science ®Google Scholar
• LewisATorvinenSDekhuijzenPNThe economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countriesBMC Health Serv Res20161625127406133
   PubMed Web of Science ®Google Scholar
• KoserAWestermanJSharmaSEmmettACraterGDSafety and efficacy of fluticasone propionate/salmeterol hydrofluoroalkane 134a metered-dose-inhaler compared with fluticasone propionate/salmeterol diskus in patients with chronic obstructive pulmonary diseaseOpen Respir Med J20104869121253451
   PubMedGoogle Scholar
• JonesRMartinJThomasVThe comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database studyInt J Chron Obstruct Pulmon Dis2017122445245428860739
   PubMed Web of Science ®Google Scholar
• AramakiEMiuraYTonoikeMExtraction of adverse drug effects from clinical recordsStud Health Technol Inform2010160Pt 173974320841784
   PubMedGoogle Scholar
• van AalderenWMGarcia-MarcosLGappaMHow to match the optimal currently available inhaler device to an individual child with asthma or recurrent wheezeNPJ Prim Care Respir Med2015251408825568979
   PubMed Web of Science ®Google Scholar
• PriceDChrystynHKaplanAEffectiveness of same versus mixed asthma inhaler devices: a retrospective observational study in primary careAllergy Asthma Immunol Res20124418419122754711
   PubMed Web of Science ®Google Scholar
• ThomasMPriceDChrystynHLloydAWilliamsAEvon ZiegenweidtJInhaled corticosteroids for asthma: impact of practice level device switching on asthma controlBMC Pulm Med20099119121204
   PubMedGoogle Scholar
• Advair hfatm (fluticasone propionate and salmeterol) [US package insert]Research triangle park NCGlaxosmithkline2017
   Google Scholar
• SpencerSEvansDJKarnerCCatesCJInhaled corticosteroids versus long-acting beta2-agonists for chronic obstructive pulmonary diseaseCochrane Database Syst Rev201110CD007033
   PubMedGoogle Scholar
• BriggsAHGlickHALozano-OrtegaGIs treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH studyEur Respir J201035353253919717476
   PubMed Web of Science ®Google Scholar
• HertelNKotchieRWSamyshkinYRadfordMHumphreysSJamesonKCost-effectiveness of available treatment options for patients suffering from severe COPD in the UK: a fully incremental analysisInt J Chron Obstruct Pulmon Dis2012718319922500119
   PubMed Web of Science ®Google Scholar
• Rutten-van MölkenMPMHGoossensLMACost effectiveness of pharmacological maintenance treatment for chronic obstructive pulmonary diseasePharmacoeconomics201230427130222409290
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
   PubMed Web of Science ®Google Scholar
• DolovichMBAhrensRCHessDRDevice selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and ImmunologyChest2005127133537115654001
   PubMed Web of Science ®Google Scholar
• PriceDRocheNChristian VirchowJDevice type and real-world effectiveness of asthma combination therapy: an observational studyRespir Med2011105101457146621612903
   PubMed Web of Science ®Google Scholar
• RachelefskyGSLiaoYFaruqiRImpact of inhaled corticosteroid-induced oropharyngeal adverse events: results from a meta-analysisAnn Allergy Asthma Immunol200798322523817378253
   PubMed Web of Science ®Google Scholar
• DekhuijzenPNRBatsiouMBjermerLIncidence of oral thrush in patients with COPD prescribed inhaled corticosteroids: Effect of drug, dose, and deviceRespir Med2016120546327817816
   PubMed Web of Science ®Google Scholar
• van BovenJFde Jong-van den BergLTVegterSInhaled corticosteroids and the occurrence of oral candidiasis: a prescription sequence symmetry analysisDrug Saf201336423123623516006
   PubMed Web of Science ®Google Scholar
• BroedersMEMolemaJHopWCVermueNAFolgeringHTThe course of inhalation profiles during an exacerbation of obstructive lung diseaseRespir Med200498121173117915588037
   PubMed Web of Science ®Google Scholar
• BorgströmLAskingLLipniunasPAn in vivo and in vitro comparison of two powder inhalers following storage at hot/humid conditionsJ Aerosol Med200518330431016181005
   PubMedGoogle Scholar
• JansonCLööfTTelgGStratelisGNilssonFDifference in resistance to humidity between commonly used dry powder inhalers: an in vitro studyNPJ Prim Care Respir Med2016261605327853177
   PubMed Web of Science ®Google Scholar
• SteinBDBautistaASchumockGTThe validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbationsChest20121411879321757568
   PubMed Web of Science ®Google Scholar
• GindeAATsaiCLBlancPGCamargoCAPositive predictive value of ICD-9-CM codes to detect acute exacerbation of COPD in the emergency departmentJt Comm J Qual Patient Saf2008341167868019025089
   PubMedGoogle Scholar